SOBHANI, NAVID
 Distribuzione geografica
Continente #
NA - Nord America 2.171
EU - Europa 1.543
AS - Asia 399
OC - Oceania 5
SA - Sud America 5
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.125
Nazione #
US - Stati Uniti d'America 2.160
PL - Polonia 796
IT - Italia 290
SE - Svezia 203
CN - Cina 154
HK - Hong Kong 123
IE - Irlanda 86
DE - Germania 41
SG - Singapore 39
UA - Ucraina 27
BG - Bulgaria 24
VN - Vietnam 22
TR - Turchia 20
FI - Finlandia 19
GB - Regno Unito 18
MY - Malesia 16
BE - Belgio 11
CA - Canada 9
IN - India 8
IR - Iran 6
JP - Giappone 5
BR - Brasile 3
CH - Svizzera 3
ES - Italia 3
FR - Francia 3
MD - Moldavia 3
NZ - Nuova Zelanda 3
PH - Filippine 3
RO - Romania 3
AR - Argentina 2
CZ - Repubblica Ceca 2
MX - Messico 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AT - Austria 1
AU - Australia 1
CI - Costa d'Avorio 1
GR - Grecia 1
KR - Corea 1
LU - Lussemburgo 1
ME - Montenegro 1
MK - Macedonia 1
NL - Olanda 1
NP - Nepal 1
RS - Serbia 1
RU - Federazione Russa 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
WS - Samoa 1
Totale 4.125
Città #
Warsaw 796
Fairfield 354
Chandler 214
Ashburn 197
Houston 193
Woodbridge 173
Seattle 135
Hong Kong 122
Ann Arbor 118
Cambridge 115
Trieste 109
Wilmington 107
Menlo Park 88
Princeton 49
Beijing 40
Jacksonville 37
Dublin 26
Sofia 24
Boardman 23
Singapore 23
Columbus 22
Dearborn 22
Dong Ket 22
Redwood City 19
Bremen 17
Izmir 17
San Diego 16
Helsinki 15
Duino-Aurisina 14
Montegaldella 11
Brussels 9
Milan 8
Nanjing 8
Udine 8
Redmond 7
Kunming 6
Norwalk 6
Phoenix 6
Tianjin 6
Dongguan 5
Hefei 5
Padova 5
Cagliari 4
Fremont 4
Frosinone 4
Fuzhou 4
Hangzhou 4
Kherson 4
London 4
Shanghai 4
Shenyang 4
Tehran 4
Toronto 4
Auckland 3
Bloomsbury 3
Buffalo 3
Capriate San Gervasio 3
Changsha 3
Chisinau 3
Durham 3
Florence 3
Guangzhou 3
Jinan 3
Kocaeli 3
Los Angeles 3
Mountain View 3
Nanchang 3
New York 3
Savignano sul Panaro 3
Taiyuan 3
Taizhou 3
Tokyo 3
Zamboanga City 3
Zhengzhou 3
Alpharetta 2
Atlanta 2
Aurora 2
Beinasco 2
Bern 2
Bethesda 2
Buenos Aires 2
Clarkesville 2
Cordenons 2
Falls Church 2
Ferrara 2
Hebei 2
Huixquilucan de Degollado 2
Karlsruhe 2
Ladispoli 2
Lappeenranta 2
Modugno 2
New Delhi 2
Ningbo 2
Pune 2
Saint John 2
São Paulo 2
Toenisvorst 2
Venezia 2
Venice 2
Verona 2
Totale 3.356
Nome #
Cyclin dependent kinase 4 and 6 inhibitors as novel therapeutic agents for targeted treatment of malignant mesothelioma 368
The predictive role of the immune system for response to therapy and survival in patients with solid tumors. 324
Cell-free DNA integrity for the monitoring of breast cancer: Future perspectives? 312
Advances in systemic therapy for metastatic breast cancer: future perspectives 298
Bevacizumab in small cell lung cancer 261
Current status of PI3K-mTOR inhibition in hormone-receptor positive, HER2-negative breast cancer 246
Tumour infiltrating lymphocytes and immune-related genes as predictors of outcome in pancreatic adenocarcinoma 239
Need for randomized clinical trials testing targeted therapies in malignant pleural mesothelioma 231
PAK6-Associated Support Vector Machine Classifier: A New Way to Evaluate Response and Survival of Gastric Cancer Treated by 5-FU/Oxaliplatin Chemotherapy 224
Tumour infiltrating lymphocytes and PD-L1 expression as potential predictors of outcome in patients with malignant pleural mesothelioma 199
Advances in systemic therapy for malignant mesothelioma: Future perspectives 169
The prognostic value of PI3K mutational status in breast cancer: A meta-analysis 164
PROGNOSTIC ROLE OF TUMOR INFILTRATING LYMPHOCITES (TILS) IN EPITHELIOID PLEURAL MESOTHELIOMA 158
Lenvatinib for the treatment of renal cell carcinoma 123
Current status of androgen receptor-splice variant 7 inhibitor niclosamide in castrate-resistant prostate-cancer 122
Corticosteroid switch after progression on abiraterone acetate plus prednisone 121
Erratum to: Advances in systemic therapy for metastatic breast cancer: future perspectives (Medical Oncology, (2017), 34, 7, (119), 10.1007/s12032-017-0975-5) 97
Avelumab in gastric cancer 61
Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory study 58
Mutant p53 as an antigen in cancer immunotherapy 55
Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast Cancer 53
Targeting Aberrant FGFR Signaling to Overcome CDK4/6 Inhibitor Resistance in Breast Cancer 45
CTLA-4 in Regulatory T Cells for Cancer Immunotherapy 44
Early changes of the standardized uptake values (SUVmax) predict the efficacy of everolimus-exemestane in patients with hormone receptor-positive metastatic breast cancer 44
Immune-related pan-cancer gene expression signatures of patient survival revealed by NanoString-based analyses 43
Analysis of PD-L1 and CD3 Expression in Glioblastoma Patients and Correlation with Outcome: A Single Center Report 40
P53 antibodies as a diagnostic marker for cancer: A meta-analysis 36
Epithelioid Mesothelioma Patients with Very Long Survival Display Defects in DNA Repair 26
Nanoparticle albumin-bound paclitaxel: a big nano for the treatment of gastric cancer 24
Immune-gene signature: A new tool for patient selection for checkpoint inhibitors? 17
Clinico-Immunological Effects of a Single-Agent CDK4/6 Inhibitor in Advanced HR+/HER2- Breast Cancer Based on a Window of Opportunity Study 17
Updates on the CDK4/6 inhibitory strategy and combinations in breast cancer 16
Predictive and Prognostic Value of Non-Coding RNA in Breast Cancer 14
Cancer management during the COVID-19 world pandemic 14
The combination of bevacizumab with chemotherapy is more beneficial in the metastatic setting rather than in the adjuvant setting for the treatment of HER2-negative breast cancer—a commentary on the E5103 randomized phase III clinical study 11
The fibroblast growth factor receptors in breast cancer: From oncogenesis to better treatments 5
Totale 4.279
Categoria #
all - tutte 10.902
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.902


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.146 0 53 70 153 64 112 111 58 155 208 108 54
2020/2021900 84 157 113 65 96 60 72 50 49 78 38 38
2021/2022448 31 42 43 37 10 38 26 14 53 61 17 76
2022/2023589 58 100 73 77 50 77 3 62 49 10 21 9
2023/2024514 13 65 56 45 33 42 102 75 2 26 29 26
2024/202517 10 7 0 0 0 0 0 0 0 0 0 0
Totale 4.279